project id: TCGA-SARC; case submitter id: TCGA-MJ-A68J; selected normal wgs: true; source center: 23; state: released; a260 a280 ratio: 1.92; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.48; rna integrity number: 8.0; age at index: 55; days to birth: -20100; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1957; age at diagnosis: 20100; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 547.0; icd 10 code: C49.2; last known disease status: not reported; morphology: 8811/3; primary diagnosis: Fibromyxosarcoma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Connective, subcutaneous and other soft tissues of lower limb and hip; synchronous malignancy: No; tissue or organ of origin: Connective, subcutaneous and other soft tissues of lower limb and hip; tumor grade: Not Reported; year of diagnosis: 2012; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 465; days to sample procurement: 0; initial weight: 80.0; portion submitter id: TCGA-MJ-A68J-01A-11; percent lymphocyte infiltration: 2.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 60.0; percent tumor cells: 40.0; percent tumor nuclei: 100.0;